Author:
Kobayashi Satoshi,Ueno Makoto,Ogawa Gakuto,Fukutomi Akira,Ikeda Masafumi,Okusaka Takuji,Sato Tosiya,Ito Yoshinori,Kadota Tomohiro,Ioka Tatsuya,Sugimori Kazuya,Sata Naohiro,Nakamori Shoji,Shimizu Kyoko,Mizuno Nobumasa,Ishii Hiroshi,Furuse Junji
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Endocrinology,Hepatology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference29 articles.
1. Clinical practice guidelines for pancreatic cancer 2019 from the Japan Pancreas Society: a synopsis;Pancreas,2020
2. Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats;Cancer Res,1996
3. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01);Lancet,2016
4. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial;Lancet Oncol,2008
5. Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial;Lancet Oncol,2013
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献